ApprovalTrail

Approval · Notice of Compliance 3343 · 1997

EUCARDIC: Notice of Compliance 3343

Issued July 29, 1997

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3343
Date
July 29, 1997
Company
Boehringer Mannheim (Canada) LteeLaval, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Congestive heart failure agent

Products in this notice

BrandDINStatus today
EUCARDIC02231763—
EUCARDIC02231764—
EUCARDIC02231765—
EUCARDIC02231766—

Medicinal ingredients